The service did not specify the citizenship of the volunteer. However, according to the University of Sao Paulo, which helps coordinate the third phase of the clinical trial, he was Brazilian.
The information is still confused, with Russia Today broadcasting - citing the Brazilian health authorities, that the man died after complications of the disease.